Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Mar-21 4:35 PM View:  | Tobin James R Director | Oxford Immunotec Global Plc (OXFD) | 08-Mar-21 | Disposition | 4,081 | $22.00 | $89,782.00 | (100%) 4.08K to 0 | < 1% |
| 12-Mar-21 4:36 PM View: | Kidd Janet Louise General Counsel | Oxford Immunotec Global Plc (OXFD) | 08-Mar-21 | Disposition | 11,207 | $22.00 | $246,554.00 | (100%) 11.21K to 0 | < 1% |
| 12-Mar-21 4:36 PM View: | Balthrop Patrick J Director | Oxford Immunotec Global Plc (OXFD) | 08-Mar-21 | Disposition | 8,081 | $22.00 | $177,782.00 | (100%) 8.08K to 0 | < 1% |
| 12-Mar-21 4:37 PM View: | Rosenman Herm Director | Oxford Immunotec Global Plc (OXFD) | 08-Mar-21 | Disposition | 4,081 | $22.00 | $89,782.00 | (100%) 4.08K to 0 | < 1% |
| 12-Mar-21 4:36 PM View: | Sandberg Richard A Director | Oxford Immunotec Global Plc (OXFD) | 08-Mar-21 | Disposition | 4,081 | $22.00 | $89,782.00 | (100%) 4.08K to 0 | < 1% |
| 12-Mar-21 4:36 PM View: | Klausner Mark R. Director | Oxford Immunotec Global Plc (OXFD) | 08-Mar-21 | Disposition | 4,081 | $22.00 | $89,782.00 | (100%) 4.08K to 0 | < 1% |
| 12-Mar-21 4:37 PM View: | McLaughlin Matthew T E Chief Financial Officer | Oxford Immunotec Global Plc (OXFD) | 08-Mar-21 | Disposition | 61,407 | $22.00 | $1,350,950.00 | (100%) 61.41K to 0 | < 1% |
| 12-Mar-21 4:35 PM View: | Walton Andrew Scott Director | Oxford Immunotec Global Plc (OXFD) | 08-Mar-21 | Disposition | 4,081 | $22.00 | $89,782.00 | (100%) 4.08K to 0 | < 1% |
| 12-Mar-21 4:35 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 08-Mar-21 | Disposition | 400,225 | $22.00 | $8,804,950.00 | (100%) 400.23K to 0 | < 1% |
| 12-Mar-21 4:35 PM View: | Andrews Ronald Asbury Director | Oxford Immunotec Global Plc (OXFD) | 08-Mar-21 | Disposition | 4,081 | $22.00 | $89,782.00 | (100%) 4.08K to 0 | < 1% |
| 12-Mar-21 4:36 PM View: | Randall Patricia Director | Oxford Immunotec Global Plc (OXFD) | 08-Mar-21 | Disposition | 27,805 | $22.00 | $611,710.00 | (100%) 27.8K to 0 | < 1% |
| 26-Jun-20 4:03 PM View: | Walton Andrew Scott Director | Oxford Immunotec Global Plc (OXFD) | 24-Jun-20 | Grant | 4,081 | -- | -- | 100% 0 to 4.08K | |
| 26-Jun-20 4:05 PM View: | Andrews Ronald Asbury Director | Oxford Immunotec Global Plc (OXFD) | 24-Jun-20 | Grant | 4,081 | -- | -- | 100% 0 to 4.08K | |
| 26-Jun-20 4:04 PM View: | Randall Patricia Director | Oxford Immunotec Global Plc (OXFD) | 24-Jun-20 | Grant | 4,081 | -- | -- | 17% 23.72K to 27.8K | |
| 26-Jun-20 4:03 PM View: | Tobin James R Director | Oxford Immunotec Global Plc (OXFD) | 24-Jun-20 | Grant | 4,081 | -- | -- | 100% 0 to 4.08K | |
| 26-Jun-20 4:05 PM View: | Balthrop Patrick J Director | Oxford Immunotec Global Plc (OXFD) | 24-Jun-20 | Grant | 4,081 | -- | -- | 100% 0 to 4.08K | |
| 26-Jun-20 4:04 PM View: | Rosenman Herm Director | Oxford Immunotec Global Plc (OXFD) | 24-Jun-20 | Grant | 4,081 | -- | -- | 100% 0 to 4.08K | |
| 26-Jun-20 4:03 PM View: | Sandberg Richard A Director | Oxford Immunotec Global Plc (OXFD) | 24-Jun-20 | Grant | 4,081 | -- | -- | 100% 0 to 4.08K | |
| 26-Jun-20 4:04 PM View: | Klausner Mark R. Director | Oxford Immunotec Global Plc (OXFD) | 24-Jun-20 | Grant | 4,081 | -- | -- | 100% 0 to 4.08K | |
| 21-May-20 4:31 PM View: | Balthrop Patrick J Director | Oxford Immunotec Global Plc (OXFD) | 20-May-20 | Market Purchase | 4,000 | $12.48 | $49,920.00 | 100% 0 to 4.0K | 76% |
| 12-May-20 4:49 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 12-May-20 | Market Purchase | 15,525 | $11.56 | $179,469.00 | 4% 384.7K to 400.23K | 90% |
| 12-May-20 4:49 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 11-May-20 | Market Purchase | 26,000 | $11.45 | $297,700.00 | 7% 358.7K to 384.7K | 92% |
| 12-May-20 4:49 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 08-May-20 | Market Purchase | 2,075 | $10.75 | $22,306.20 | < 1% 356.63K to 358.7K | 105% |
| 13-Mar-20 4:32 PM View: | Randall Patricia Director | Oxford Immunotec Global Plc (OXFD) | 12-Mar-20 | Option Exercise | 15,074 | $0.09 | $1,356.66 | 174% 8.65K to 23.72K | |
| 13-Mar-20 4:33 PM View: | McLaughlin Matthew T E Chief Financial Officer | Oxford Immunotec Global Plc (OXFD) | 11-Mar-20 | Grant | 34,795 | -- | -- | 131% 26.61K to 61.41K | |
| 13-Mar-20 4:31 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 11-Mar-20 | Grant | 62,087 | -- | -- | 21% 294.54K to 356.63K | |
| 13-Mar-20 4:32 PM View: | Linn Stefan C Chief Operating Officer | Oxford Immunotec Global Plc (OXFD) | 11-Mar-20 | Grant | 37,235 | -- | -- | 63% 59.07K to 96.3K | |
| 20-Nov-19 4:00 PM View: | Kidd Janet Louise General Counsel | Oxford Immunotec Global Plc (OXFD) | 18-Nov-19 | Grant | 11,207 | -- | -- | 100% 0 to 11.21K | |
| 05-Nov-19 4:02 PM View: | Sandberg Richard A Director | Oxford Immunotec Global Plc (OXFD) | 01-Nov-19 | Option Exercise | 3,000 | $3.94 | $11,826.00 | 100% 0 to 3.0K | |
| 05-Nov-19 4:02 PM View: | Sandberg Richard A Director | Oxford Immunotec Global Plc (OXFD) | 01-Nov-19 | Market Option Sale | 3,000 | $15.60 | $46,800.00 | (100%) 3.0K to 0 | (41%) |
| 03-Oct-19 4:01 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 01-Oct-19 | Market Sale (Planned) | 30,000 | $16.21 | $486,402.00 | (9%) 324.54K to 294.54K | (36%) |
| 25-Sep-19 4:00 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 24-Sep-19 | Market Sale (Planned) | 80,000 | $17.01 | $1,361,100.00 | (20%) 404.54K to 324.54K | (29%) |
| 25-Sep-19 4:00 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 23-Sep-19 | Market Sale (Planned) | 20,000 | $14.92 | $298,366.00 | (5%) 424.54K to 404.54K | (47%) |
| 20-Aug-19 4:32 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 16-Aug-19 | Market Sale (Planned) | 10,000 | $13.86 | $138,647.00 | (2%) 434.54K to 424.54K | (59%) |
| 05-Aug-19 4:30 PM View: | Sandberg Richard A Director | Oxford Immunotec Global Plc (OXFD) | 01-Aug-19 | Private Sale (Planned) | 3,000 | $19.90 | $59,702.70 | (100%) 3.0K to 0 | |
| 03-May-19 4:31 PM View: | Sandberg Richard A Director | Oxford Immunotec Global Plc (OXFD) | 01-May-19 | Market Sale (Planned) | 3,000 | $16.05 | $48,155.10 | (50%) 6.0K to 3.0K | (37%) |
| 10-Apr-19 4:55 PM View: | McLaughlin Matthew T E Chief Financial Officer | Oxford Immunotec Global Plc (OXFD) | 08-Apr-19 | Grant | 26,612 | -- | -- | 100% 0 to 26.61K | |
| 03-Apr-19 4:30 PM View: | Linn Stefan C Chief Operating Officer | Oxford Immunotec Global Plc (OXFD) | 01-Apr-19 | Grant | 20,901 | -- | -- | 55% 38.16K to 59.07K | |
| 03-Apr-19 4:30 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 01-Apr-19 | Market Sale (Planned) | 10,600 | $16.68 | $176,772.00 | (2%) 445.14K to 434.54K | (32%) |
| 03-Apr-19 4:30 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 01-Apr-19 | Grant | 31,669 | -- | -- | 8% 413.47K to 445.14K | |
| 06-Mar-19 4:30 PM View: | Keiley Elizabeth M SVP & General Counsel | Oxford Immunotec Global Plc (OXFD) | 04-Mar-19 | Market Sale (Planned) | 4,100 | $17.00 | $69,711.90 | (13%) 31.03K to 26.93K | (29%) |
| 20-Feb-19 4:30 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 19-Feb-19 | Market Sale (Planned) | 10,000 | $16.99 | $169,934.00 | (2%) 423.47K to 413.47K | (29%) |
| 01-Feb-19 4:30 PM View: | Sandberg Richard A Director | Oxford Immunotec Global Plc (OXFD) | 01-Feb-19 | Market Sale (Planned) | 3,000 | $14.25 | $42,750.90 | (33%) 9.0K to 6.0K | (54%) |
| 11-Jan-19 4:35 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 10-Jan-19 | Market Sale (Planned) | 10,000 | $14.91 | $149,073.00 | (2%) 433.47K to 423.47K | (48%) |
| 03-Jan-19 10:00 PM View: | Altieri Richard M. Chief Financial Officer | Oxford Immunotec Global Plc (OXFD) | 01-Jan-19 | Payment of Exercise | 2,926 | $12.78 | $37,394.30 | (1%) 210.89K to 207.97K | (72%) |
| 03-Jan-19 4:30 PM View: | Keiley Elizabeth M SVP & General Counsel | Oxford Immunotec Global Plc (OXFD) | 01-Jan-19 | Payment of Exercise | 1,605 | $12.78 | $20,511.90 | (5%) 32.63K to 31.03K | (72%) |
| 01-Nov-18 4:30 PM View: | Sandberg Richard A Director | Oxford Immunotec Global Plc (OXFD) | 01-Nov-18 | Market Sale (Planned) | 3,000 | $15.50 | $46,500.00 | (25%) 12.0K to 9.0K | (42%) |
| 03-Oct-18 4:30 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 02-Oct-18 | Market Sale (Planned) | 10,000 | $16.93 | $169,260.00 | (2%) 443.47K to 433.47K | (30%) |
| 03-Oct-18 4:30 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 01-Oct-18 | Market Sale (Planned) | 10,000 | $16.50 | $165,000.00 | (2%) 453.47K to 443.47K | (33%) |
| 27-Sep-18 4:30 PM View: | Wrighton-Smith Peter Chief Executive Officer Director | Oxford Immunotec Global Plc (OXFD) | 25-Sep-18 | Option Exercise | 54,273 | $0.81 | $43,961.10 | 11% 485.3K to 539.57K |
